Latest Breaking News On - David novitski - Page 1 : vimarsana.com

Recent Surge for Intellectual Property & Patents in Psychedelic Therapies & Drug Development News provided by Share this article Financialnewsmedia.com News Commentary PALM BEACH, Fla., June 15, 2021 /PRNewswire/ The modern psychedelic renaissance has empirically proven that psychedelic drugs are going to revolutionize mental health treatment. Before these incredibly promising medicines can get to the people who need them the most, they must pass through the extensive drug development pipeline, where IP & Patents are crucial. It seems that a week doesn t go by without a psychedelic company saying it has filed for a new patent. An informative article on Microdose explains the reasons why psychedelic companies are pursuing these patents. First, the plants that the medicines are based on can t be patented. Products in nature belong to the public and thus can t be patented. Microdose wrote, One company cannot claim it as intellectual property to exclusively profit from it. How

United statesUnited kingdomBritish columbiaMatthias liechtiDavid novitskiPaul pedersenBritish american tobaccoFn media groupCardiol therapeutics incTrademark officeNextleaf solutionsSpecialty molecules divisionHealth numinusYougov plcNextleaf solutions ltdOptimi health corp